Each of the 34 studies reviewed “reported improvement in the insomnia symptoms of at least a portion of their participants.”
Topic: CBD
“[T]he ability of whole-plant cannabis extracts to reduce opioid reward and drug seeking behavior appears quite robust and of great clinical utility,” authors concluded.
“CBD may be appropriate for RAU patients who choose not to take topical steroids,” scientists concluded.
The agency had previously opined that regulating hemp-derived CBD products as dietary supplements could potentially discourage the use and development of CBD prescription drugs.
“Our research found CBC to enhance the cytotoxic effect of CBD, establishing additional support for the phenomenon of the entourage effect,” investigators concluded.
Regulators are hopeful that the commission’s actions may clear the way for the opening of state-licensed dispensaries by this spring.
Over 90 percent of subjects treated with the combination therapy experienced a ≥50 percent reduction in seizure frequency at six-months.
Patients in the treatment group experienced a decrease in pain of 29 percent over the course of the trial, whereas those in the control group only experienced a six percent decrease.